Iatrogenic Cushing's disease in a boy after misdiagnosis of salt-losing virilizing adrenal hyperplasia: impaired metyrapone response with failure of catch-up growth.
D015068:17-Ketosteroids / Q000652:urine; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis*; D000309:Adrenal Insufficiency / Q000175:diagnosis*; D000324:Adrenocorticotropic Hormone; D001835:Body Weight; D001846:Bone Development; D002648:Child; D002675:Child, Preschool; D003480:Cushing Syndrome / Q000139:chemically induced*; D003900:Desoxycorticosterone / Q000009:adverse effects; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D005438:Fludrocortisone / Q000009:adverse effects; D005938:Glucocorticoids / Q000009:adverse effects*; D006130:Growth Disorders / Q000139:chemically induced*; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects / Q000097:blood; D007223:Infant; D007231:Infant, Newborn; D007328:Insulin; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects; D008797:Metyrapone; D008901:Mineralocorticoids / Q000009:adverse effects*; D010912:Pituitary-Adrenal Function Tests
D015068:17-Ketosteroids; D005938:Glucocorticoids; D007328:Insulin; D008901:Mineralocorticoids; D003900:Desoxycorticosterone; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D005438:Fludrocortisone; D006854:Hydrocortisone; D008775:Methylprednisolone; D008797:Metyrapone